cabosun trial of cabozantinib - could it change how we treat frontline rcc?
Published 7 years ago • 680 plays • Length 4:12Download video MP4
Download video MP3
Similar videos
-
5:08
cabosun trial of upfront cabozantinib in metastatic rcc
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
6:26
esmo 2016: press brief on results of cabosun trial cabozantinib compared to sunitinib in rcc
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
3:21
cabosun trial: cabozantinib vs sunitinib for renal cell carcinoma
-
1:44
dr. choueiri on cabosun trial results in rcc
-
2:02
how cabozantinib is being used in practice for patients with rcc
-
1:45
dr. choueiri on cabosun trial results for rcc
-
1:25
managing side effects of cabozantinib treatment for metastatic renal cell carcinoma
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
2:28
the role of cabozantinib in renal cell carcinoma
-
0:54
phase ib/ii trial of 177lu-girentuximab with cabozantinib and nivolumab in clear cell rcc
-
2:40
updates on the cabopre phase ii trial in patients with metastatic renal cell carcinoma
-
4:09
subgroup analyses of meteor; randomized phase iii trial of cabozantinib vs everolimus for rcc
-
10:01
undergoing treatment: cabozantinib toxicity management
-
1:06
dr. choueiri on fda approval of cabozantinib for rcc
-
0:56
dr. gupta on the cabosun trial for rcc
-
5:31
newly diagnosed metastatic renal cell carcinoma
-
5:56
the rationale for cabozantinib in advanced rcc